Delay in Available Antimicrobial Susceptibility Tests Undermines Proper Antibiotic Use
July 4th 2017Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how the role of antimicrobial susceptibility tests can be undermined by delays between approval of new antibiotics and the tests that will optimize their use.
Read More
Why is Multidrug-Resistant Pseudomonas aeruginosa a Priority Pathogen?
June 13th 2017Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.
Read More